Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Markus Joerdens
Institution:
Düsseldorf University Hospital
Observed institution:
Düsseldorf University Hospital
OpenAlex ID:
A5158826319
Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092)
2026
·
Carolin Angendohr
, Christian Weigel
, et al.
·
Figshare
Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092)
2026
·
Carolin Angendohr
, Christian Weigel
, et al.
·
Future Oncology
PDF
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type